Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Zhijun Dai

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. MiR-429 suppresses neurotrophin-3 to alleviate perineural invasion of pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2018.09.147↗
  2. Antitumor effects of rapamycin in pancreatic cancer cells by inducing apoptosis and autophagy. Co-author DOI 10.3390/ijms14010273↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Di Liu · 1 shared paper, 2018 · strength 0.08
  2. Shuqun Zhang · 1 shared paper, 2018 · strength 0.08
  3. Wenying Wu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.